IN-SITU HYBRIDIZATION MARKET ANALYSIS

In-situ Hybridization Market, by Product Type (Assay Kits and Probes, Reagents, and Instruments), by Hybridization Technique (Fluorescence In-Situ Hybridization and Chromogenic In-Situ Hybridization), by Application (Cancer Diagnosis, Cytogenetics, Developmental Biology, Infectious Diseases, Immunology, and Others), by End User (Research and Academic Institutes, Diagnostic Laboratories, Pharmaceutical and Biotech Companies, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI2057
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

In-situ Hybridization Market- Regional Insights

On the basis of geography, the global in-situ hybridization market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the in-situ hybridization market over the forecast period. U.S. has high incidence of different types of cancer. According to the American Cancer Society factsheet published in 2018, cancer is the second leading cause of death after cardio vascular disease. Furthermore, around 1.7 million new cancer cases and over half million death is projected to occur in 2018. Moreover, the presence of key players that supplies advanced assay kits and probes for diagnostic and research and development activities in the U.S. would boost growth of the market in this region.

IN-SITU HYBRIDIZATION MARKET ANALYSIS

Regional Analysis

In-situ Hybridization Market Report Snapshots

EXISTING CLIENTELE